panaxydol has been researched along with Lung Injury, Acute in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Han, W; Hao, W; Li, J; Liu, M; Lu, K; Lv, W; Sheng, W; Sun, F; Tan, S; Zhang, X | 1 |
1 other study(ies) available for panaxydol and Lung Injury, Acute
| Article | Year |
|---|---|
Panaxydol attenuates ferroptosis against LPS-induced acute lung injury in mice by Keap1-Nrf2/HO-1 pathway.
Topics: Acute Lung Injury; Animals; Cell Line; Diynes; Fatty Alcohols; Ferroptosis; Heme Oxygenase-1; Humans; Kelch-Like ECH-Associated Protein 1; Lipopolysaccharides; Lung; Mice; Mice, Inbred C57BL; NF-E2-Related Factor 2 | 2021 |